Hjem › Ulcerøs kolitt › California › Lancaster
Kliniske studier for Ulcerøs kolitt i Lancaster, CA
7 studier for Ulcerøs kolitt søker deltakere på steder i og rundt Lancaster (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
RekruttererFase 2
- Gastro Care Institute /ID# 281071, Lancaster
A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis
RekruttererFase 2
- Om Research, LLC, Lancaster
A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
RekruttererFase 2
- Site 012, Lancaster
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC)
RekruttererFase 2
- Gastro Care Institute, Lancaster
A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
RekruttererFase 3
- Om Research LLC, Lancaster
LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
RekruttererFase 2
- Om Research LLC, Lancaster
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
RekruttererFase 3
- Om Research, LLC - Lancaster - Site Number: 8400148, Lancaster
Ulcerøs kolitt-studier i andre byer
- New York City, NY23 studier
- Orlando, FL22 studier
- Miami, FL21 studier
- Houston, TX17 studier
- San Antonio, TX16 studier
- Tacoma, WA15 studier
- Chicago, IL15 studier
- San Diego, CA15 studier
- Tyler, TX14 studier
- Colorado Springs, CO14 studier
- Los Angeles, CA13 studier
- St. Louis, MO13 studier
Andre studier i Lancaster
- Steatotisk leversykdom7 studier
- Crohns sykdom7 studier
- Ikke-småcellet lungekreft4 studier
- Astma4 studier
- Type 2-diabetes4 studier
- Reaktivt tarmsyndrom3 studier
- Høyt blodtrykk3 studier
- Kardiovaskulær sykdom3 studier
- Inflammatorisk tarmsykdom3 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.